Clal Capital Raising: The 2030-2036 repayment wall is a refinancing assumption, not a hard maturity schedule

The main article already argued that what matters at Clal Capital Raising is market access, not net income. This follow-up isolates the table most likely to be over-read: projected repayments. Anyone treating the 2030-2036 concentration as a hard amortization timetable is assuming the company must repay all of that principal there. That is the wrong read.

The numbers themselves are sharp. At year-end 2025 there are five tradable series, 11 through 15. But each series has three different clocks: the first optional redemption date, the projected repayment year the company shows, and the legal final maturity. For series 11 through 14, the table does not assume redemption at the first possible call date and it does not assume legal final maturity either. It assumes redemption at the economic point where not calling the instrument becomes more expensive. For series 15, the gap is far larger: the projected repayment sits in 2036, while legal final maturity only sits in 2075.

The chart shows what the table is really doing. It pulls the whole stack to the left. For series 11 through 14, that pull is three years. For series 15, it is 39 years, because the company places the principal in 2036 even though legal final maturity is October 31, 2075. That is why the wall should be read as a refinancing assumption. It does not describe when principal must be repaid under the trust deeds. It describes when holding the instruments is assumed to stop being economically attractive for the issuer.

Why the company assumes 2030 through 2036

Series 11 through 14: not the first call date, but the point where not calling gets more expensive

The annual report gives a clear clue here. The first optional redemption date for series 11 is already March 31, 2027, for series 12 it is March 31, 2030, for series 13 it is July 31, 2032, and for series 14 it is September 30, 2034. Yet the projected repayment table does not sit on those years. It sits on 2030, 2032, 2034, and 2036.

That is not a contradiction. It is the economics of the instruments. Starting three years before legal principal maturity, if the company has not redeemed the full series, an extra coupon equal to 50% of the original credit spread is added for series 11 through 14. In other words, the table does not assume the company will rush to call as soon as it is allowed. It assumes the company will carry the series until the point where not calling it starts to become more expensive.

That is also why the table only shows interest through 2030 for series 11, through 2032 for series 12, through 2034 for series 13, and through 2036 for series 14. If this were a legal-maturity table, both interest and principal would run through 2033, 2035, 2037, and 2039. What the company is presenting is an economic exit point, not the contractual end of life of the notes.

Series 15: not a step-up, but a coupon reset

Series 15 works differently, and this is exactly where the 2036 wall is most misleading. Legal final maturity is October 31, 2075. The first optional redemption date is October 31, 2036. If the company does not exercise that right by then, the coupon does not simply get a 50% add-on to the original spread as it does in series 11 through 14. Instead, from October 31, 2036 and every five years after that, the coupon resets to the five-year Israeli government bond yield plus a fixed spread of 1.15607%.

That wording difference matters a great deal. It means series 15 is not built like a normal bond whose principal somehow collapses into 2036. It is built as a very long-dated capital instrument with a first call window in 2036 and then additional windows every five years on the next interest payment date. So when the table places all of series 15 principal in 2036, it is not telling the reader when the principal must legally be repaid. It is telling the reader when the company assumes it will be economically preferable, or necessary, to refinance the instrument.

That is the core economic point. For series 11 through 14, the assumption is that the company will not want to enter the last three, more expensive years. For series 15, the assumption is that the company will not want to enter a five-year reset regime tied to a fresh government yield. In both cases, the wall presented to the reader is a wall of incentives, not a wall of contractual obligation.

What changes if refinancing conditions deteriorate

The practical implication is that the 2030-2036 repayment wall can break in two different ways, and neither one looks like a standard failure to meet a fixed maturity schedule.

For series 11 through 14, if refinancing conditions are weaker, principal does not need to disappear or move immediately into a stress event. It can simply shift right, from the projected table back to the legal final maturities of 2033, 2035, 2037, and 2039. The cost of that delay is more expensive capital, because the final three years carry the extra coupon equal to 50% of the original credit spread. So the real risk here is not a hard wall. It is a move into a more expensive capital layer.

For series 15, the change is sharper still. If 2036 arrives in a weaker refinancing environment, the company is not automatically thrown into a principal payment of ILS 1.1496 billion. The instrument can remain outstanding, the coupon can move into the five-year reset regime, and later redemption windows only recur every five years. That does not make the risk trivial. It does change its nature. The risk shifts from a hard principal wall to the possibility of remaining much longer with deeper, more expensive capital in the structure.

There is another reason the table is a refinancing assumption and not a hard schedule. Every early redemption requires approval from the supervisor. In addition, for all series, early redemption can also be executed if Clal Insurance concurrently issues a capital instrument of the same or better quality. Put simply, the table is not only assuming issuer willingness to redeem. It is also assuming regulatory room and replacement capital availability.

The post-balance-sheet event reinforces that reading rather than contradicting it. In January 2026 the company expanded series 15 by another ILS 590.607 million par for about ILS 622 million of proceeds. That means the refinancing market was still functioning at the start of 2026. But that is evidence of market access, not proof that 2036 is a hard maturity date. If anything, it reminds the reader that the 2030-2036 table depends on whether the market and the regulator will still allow old capital to be replaced with new capital a decade from now.

The bottom line

This continuation is not arguing that the wall does not matter. It is arguing that it should be called by the right name. It is a refinancing wall. For series 11 through 14, it sits where not calling starts to raise the cost of capital. For series 15, it sits at the first early-redemption and coupon-reset window, not at legal final maturity. Anyone reading 2030 through 2036 as if it were a stack of hard bullet maturities is missing the core logic of the instruments.

That matters even more because there are five tradable series outstanding today, 11 through 15. The market does not have to accept the company’s refinancing assumption as a given. Any future change in Clal Insurance’s solvency headroom, in investor appetite for regulatory capital, or in the ability to issue replacement capital of the same or better quality can push the center of gravity away from the projected years and back toward the legal ones. At that point, 2030 through 2036 will stop looking like a repayment timetable and will be exposed for what it already is today: an assumption that the funding market will remain open.